Meeting
2021 ASCO Annual Meeting
Variant reclassification and its impact on clinical care in an Asian cancer center.
Authors
Jianbang Chiang
National Cancer Centre Singapore, Singapore, Singapore
Jianbang Chiang , Tze Hao Chia , Sock Hoai Chan , Joanne YY Ngeow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10583)
DOI
10.1200/JCO.2021.39.15_suppl.10583
Abstract #
10583
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
First Author: Vittorio Fasulo
Poster
2023 ASCO Quality Care Symposium
Interdisciplinary implementation of a synoptic reporting template for melanoma nodal surveillance ultrasound.
First Author: Kelsey B. Montgomery
Poster
2023 ASCO Annual Meeting
Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients.
First Author: Kara K. Landry
Poster
2023 ASCO Annual Meeting
Clinical and social importance of follow-up assessment of family members of patients with BRCA mutations.
First Author: Ivana Lucia de Oliveira Nascimento